Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bivas Biswas

Showing results (61-70 of 71) with videos related to

Pageof 8
Sort By:
Cureus|June 10, 2024
Demographic Characteristics and Treatment Outcomes of Advanced Renal Cell Carcinoma With Clear Cell Histology: A Single-Center Experience From IndiaSomnath Roy, Bivas Biswas, Deepak Dabkara, et al.
American Journal of Translational Research|March 11, 2022
Development and validation of a prognostic score at baseline diagnosis for Ewing sarcoma family of tumors: a retrospective single institution analysis of 860 patientsArchana Sasi, Shuvadeep Ganguly, Bivas Biswas, et al.
Pediatric Hematology and Oncology|January 8, 2024
Treatment outcomes in patients with Ewing sarcoma of the spine in a resource-challenged setting: 17-year experience from a single center in IndiaArchana Sasi, Sindhura Chitikela, Shuvadeep Ganguly, et al.
JCO Global Oncology|March 17, 2022
Evaluating Quality Indicators of Glioblastoma Care: Audit Results From an Indian Tertiary Care Cancer CenterRimpa Basu Achari, Santam Chakraborty, Love Goyal, et al.
Indian Journal of Cancer|March 28, 2022
CONCORDANCE: A real-world evidence study to evaluate the concordance of detecting epidermal growth factor receptor (EGFR) mutation by circulating tumor DNA* versus tissue biopsy in patients with metastatic non-small cell lung cancerKumar Prabhash, Bivas Biswas, Sachin Khurana, et al.
Current Problems in Cancer|April 3, 2020
Real world experience of treatment and outcome in ALK-rearranged metastatic nonsmall cell lung cancer: A multicenter study from IndiaAmol Patel, Ullas Batra, Kuruswamy Thurai Prasad, et al.
Current Problems in Cancer|March 18, 2020
Next generation sequencing in lung cancer: An initial experience from IndiaPragya Gupta, Kallol Saha, Sushant Vinarkar, et al.
Pediatric Blood & Cancer|August 14, 2024
Ewing sarcoma among children 5 years of age or younger: Is it a different disease?Chitrakshi Nagpal, Shuvadeep Ganguly, Archana Sasi, et al.
Lung Cancer (Amsterdam, Netherlands)|December 9, 2025
Real-world use of and clinical outcomes with dacomitinib as first-line therapy in Asian patients with EGFR mutation-positive locally advanced or metastatic non-small cell lung cancer: Final analysis of the ARIA studyLin Wu, Junling Li, Chong-Rui Xu, et al.
The New England Journal of Medicine|October 17, 2025
Survival with Osimertinib plus Chemotherapy in <i>EGFR</i>-Mutated Advanced NSCLCPasi A Jänne, David Planchard, Kunihiko Kobayashi, et al.
Pageof 8

Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
Cureus|June 10, 2024
Demographic Characteristics and Treatment Outcomes of Advanced Renal Cell Carcinoma With Clear Cell Histology: A Single-Center Experience From IndiaSomnath Roy, Bivas Biswas, Deepak Dabkara, et al.
American Journal of Translational Research|March 11, 2022
Development and validation of a prognostic score at baseline diagnosis for Ewing sarcoma family of tumors: a retrospective single institution analysis of 860 patientsArchana Sasi, Shuvadeep Ganguly, Bivas Biswas, et al.
Pediatric Hematology and Oncology|January 8, 2024
Treatment outcomes in patients with Ewing sarcoma of the spine in a resource-challenged setting: 17-year experience from a single center in IndiaArchana Sasi, Sindhura Chitikela, Shuvadeep Ganguly, et al.
JCO Global Oncology|March 17, 2022
Evaluating Quality Indicators of Glioblastoma Care: Audit Results From an Indian Tertiary Care Cancer CenterRimpa Basu Achari, Santam Chakraborty, Love Goyal, et al.
Indian Journal of Cancer|March 28, 2022
CONCORDANCE: A real-world evidence study to evaluate the concordance of detecting epidermal growth factor receptor (EGFR) mutation by circulating tumor DNA* versus tissue biopsy in patients with metastatic non-small cell lung cancerKumar Prabhash, Bivas Biswas, Sachin Khurana, et al.
Current Problems in Cancer|April 3, 2020
Real world experience of treatment and outcome in ALK-rearranged metastatic nonsmall cell lung cancer: A multicenter study from IndiaAmol Patel, Ullas Batra, Kuruswamy Thurai Prasad, et al.
Current Problems in Cancer|March 18, 2020
Next generation sequencing in lung cancer: An initial experience from IndiaPragya Gupta, Kallol Saha, Sushant Vinarkar, et al.
Pediatric Blood & Cancer|August 14, 2024
Ewing sarcoma among children 5 years of age or younger: Is it a different disease?Chitrakshi Nagpal, Shuvadeep Ganguly, Archana Sasi, et al.
Lung Cancer (Amsterdam, Netherlands)|December 9, 2025
Real-world use of and clinical outcomes with dacomitinib as first-line therapy in Asian patients with EGFR mutation-positive locally advanced or metastatic non-small cell lung cancer: Final analysis of the ARIA studyLin Wu, Junling Li, Chong-Rui Xu, et al.
The New England Journal of Medicine|October 17, 2025
Survival with Osimertinib plus Chemotherapy in <i>EGFR</i>-Mutated Advanced NSCLCPasi A Jänne, David Planchard, Kunihiko Kobayashi, et al.
Pageof 8